RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Review on the Safety and Efficacy of Brolucizumab for Neovascular Age-Related Macular Degeneration From Major Studies and Real-World Data.

Review on the Safety and Efficacy of Brolucizumab for Neovascular Age-Related Macular Degeneration From Major Studies and Real-World Data.

Add to Collection
2023 Mar-Apr 01 Others Fist_Author_Year_PM

Full Author : ['Radke, Nishant V', 'Mohamed, Shaheeda', 'Brown, Richard B', 'Ibrahim, Ilyana', 'Chhablani, Jay', 'Amin, Hivam V', 'Tsang, Chi-Wai', 'Brelen, Marten E', 'Raichand, Nikhil S', 'Fang, Dong', 'Zhang, Shaochong', 'Dai, Hong', 'Chen, Guy Li Jia', 'Cheung, Chui Ming Gemmy', 'Hariprasad, Seenu M', 'Das, Taraprasad', 'Lam, Dennis S C']
Journal Title : Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
Chapter : Section3
Journal Year : 2023
Cited by : Not Available

Frequent antivascular endothelial growth factor injections in neovascular age-related macular degeneration (nAMD) often lead to poor compliance and suboptimal outcomes. A longer-acting agent has been a pressing unmet need until recently. Brolucizumab, an .....

Keywords : ["neovascular agerelate macular degeneration", "realworld datum", "major study", "safety", "review", "efficacy", "brolucizumab"]